Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
324 participants
OBSERVATIONAL
2020-11-05
2021-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories
NCT04357834
International Validation of Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms
NCT05334680
Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies
NCT04772170
Non-contact ECG Sensor System for COVID19
NCT04341506
COVID-19 Surveillance Based on Smart Wearable Device
NCT04459637
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy Adults
Adults 18 years or older
ANNE One
Wireless vital sign monitoring device
COVID19
Adults 18 years or older diagnosed with COVID 19
ANNE One
Wireless vital sign monitoring device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ANNE One
Wireless vital sign monitoring device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Recent (within 1 week) occupational or home exposure to a newly diagnosed COVID-19 infected individual
* Able and willing to give written consent and comply with study procedures
Exclusion Criteria
* The subject is pregnant, nursing or planning a pregnancy
* Inability to provide written consent
* Past confirmed COVID-19 infection with resolution of symptoms
* Past confirmed COVID-19 active infection moderate or severe symptoms
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Department of Defense
FED
Northwestern University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shuai (Steve) Xu
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northwestern Memorial Hospital
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU00213040
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.